These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 28814070)

  • 1. Human Papillomavirus Genotype-Specific Persistence and Potential Risk Factors among Korean Women: Results from a 2-Year Follow-up Study.
    Ingabire C; Lim MK; Won YJ; Oh JK
    Cancer Res Treat; 2018 Jul; 50(3):813-822. PubMed ID: 28814070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-vaccine era cervical human papillomavirus infection among screening population of women in west Austria.
    Borena W; Grünberger M; Widschwendter A; Kraxner KH; Marth E; Mayr P; Meier J; Ruth N; Guerrero AT; Marth C; Holm-von Laer D
    BMC Public Health; 2016 Aug; 16(1):889. PubMed ID: 27565569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic Human Papillomavirus Infection and Genotype Characterization among Women in Orodara, Western Burkina Faso.
    Traore IMA; Zohoncon TM; Ndo O; Djigma FW; Obiri-Yeboah D; Compaore TR; Guigma SP; Yonli AT; Traore G; Ouedraogo P; Ouedraogo CMR; Traore Y; Simpore J
    Pak J Biol Sci; 2016; 19(7):306-311. PubMed ID: 29023032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and Distribution of Human Papillomavirus Genotypes Among Women in Kinshasa, The Democratic Republic of the Congo.
    Mutombo AB; Benoy I; Tozin R; Bogers J; Van Geertruyden JP; Jacquemyn Y
    J Glob Oncol; 2019 Jul; 5():1-9. PubMed ID: 31310568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral load and short-term natural history of type-specific oncogenic human papillomavirus infections in a high-risk cohort of midadult women.
    Winer RL; Xi LF; Shen Z; Stern JE; Newman L; Feng Q; Hughes JP; Koutsky LA
    Int J Cancer; 2014 Apr; 134(8):1889-98. PubMed ID: 24136492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple-type human papillomavirus (HPV) infections: a cross-sectional analysis of the prevalence of specific types in 309,000 women referred for HPV testing at the time of cervical cytology.
    Dickson EL; Vogel RI; Bliss RL; Downs LS
    Int J Gynecol Cancer; 2013 Sep; 23(7):1295-302. PubMed ID: 23970156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of high-risk HPV genotyping in women with high-grade cervical lesions: evidence for improving the cervical cancer screening strategy in China.
    Xu H; Lin A; Shao X; Shi W; Zhang Y; Yan W
    Oncotarget; 2016 Dec; 7(50):83775-83783. PubMed ID: 27626178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted next generation sequencing panel for HPV genotyping in cervical cancer.
    Lippert J; Bønløkke S; Utke A; Knudsen BR; Sorensen BS; Steiniche T; Stougaard M
    Exp Mol Pathol; 2021 Feb; 118():104568. PubMed ID: 33171155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: Findings of initial screening and one-year follow-up.
    Cholli P; Bradford L; Manga S; Nulah K; Kiyang E; Manjuh F; DeGregorio G; Ogembo RK; Orock E; Liu Y; Wamai RG; Sheldon LK; Gona PN; Sando Z; Welty T; Welty E; Ogembo JG
    Gynecol Oncol; 2018 Jan; 148(1):118-125. PubMed ID: 29153541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type-specific prevalence and persistence of human papillomavirus in women in the United States who are referred for typing as a component of cervical cancer screening.
    Ralston Howe E; Li Z; McGlennen RC; Hellerstedt WL; Downs LS
    Am J Obstet Gynecol; 2009 Mar; 200(3):245.e1-7. PubMed ID: 19254582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of cervical human papillomavirus infection in systemic lupus erythematosus women.
    Mendoza-Pinto C; García-Carrasco M; Vallejo-Ruiz V; Méndez-Martínez S; Taboada-Cole A; Etchegaray-Morales I; Muñóz-Guarneros M; Reyes-Leyva J; López-Colombo A
    Lupus; 2017 Aug; 26(9):944-951. PubMed ID: 28059024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of risk factors for persistent infection of asymptomatic women with high-risk human papilloma virus.
    Shi N; Lu Q; Zhang J; Li L; Zhang J; Zhang F; Dong Y; Zhang X; Zhang Z; Gao W
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-7. PubMed ID: 28409676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of human papillomavirus genotype among Moroccan women during a local screening program.
    Alhamany Z; El Mzibri M; Kharbach A; Malihy A; Abouqal R; Jaddi H; Benomar A; Attaleb M; Lamalmi N; Cherradi N
    J Infect Dev Ctries; 2010 Nov; 4(11):732-9. PubMed ID: 21252451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
    Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
    Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High risk HPV infection prevalence and associated cofactors: a population-based study in female ISSSTE beneficiaries attending the HPV screening and early detection of cervical cancer program.
    Torres-Poveda K; Ruiz-Fraga I; Madrid-Marina V; Chavez M; Richardson V
    BMC Cancer; 2019 Dec; 19(1):1205. PubMed ID: 31823749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profile of MeltPro® HPV test for human papillomavirus genotyping and cervical precancer screening.
    Liao Y; Li Q
    Expert Rev Mol Diagn; 2019 Oct; 19(10):857-862. PubMed ID: 31466483
    [No Abstract]   [Full Text] [Related]  

  • 17. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
    de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
    Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of human papillomavirus infection in women with systemic sclerosis.
    Martin M; Mougin C; Prétet JL; Gil H; Meaux-Ruault N; Puzenat E; Ramanah R; Aubin F; Touzé A; Coursaget P; Jacquin E; Magy-Bertrand N
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-145-8. PubMed ID: 25151849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of human papillomavirus infection in women undergoing routine cervical cancer screening in Spain: the CLEOPATRE study.
    Roura E; Iftner T; Vidart JA; Kjaer SK; Bosch FX; Muñoz N; Palacios S; Rodriguez MS; Morillo C; Serradell L; Torcel-Pagnon L; Cortes J; Castellsagué X;
    BMC Infect Dis; 2012 Jun; 12():145. PubMed ID: 22734435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the analytical and clinical performance of five tests for the detection of human papillomavirus genital infection.
    Del Pino M; Alonso I; Rodriguez-Trujillo A; Bernal S; Geraets D; Guimerà N; Torne A; Ordi J
    J Virol Methods; 2017 Oct; 248():238-243. PubMed ID: 28739302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.